FilingSEC EDGAR8-K
Akari Therapeutics Approves Increase in Shares Available for Equity Plan
· SEC accepted
StageApproved
Filing content
The company approved an increase of 144 billion ordinary shares available for grant under its 2023 equity plan at the special general meeting.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…